NIH Approves Strategic Vision to Transform National Library of Medicine
National Institutes of Health Director Francis S. Collins, has approved a federal report that lays out the long-term scientific vision for the NIH’s National Library of Medicine (NLM), the world’s largest biomedical library.
This vision, presented at the 110th meeting of the Advisory Committee to the Director (ACD), calls for NIH to position the NLM as a unifying force in biomedicine that promotes and accelerates knowledge generation, dissemination and understanding in the United States and internationally. The report also cites the need to make NLM the epicenter for biomedical data science, not just at NIH, but across the biomedical research enterprise. In addition, the report recommends dramatically expanding NLM’s activities to include research conducted beyond NIH’s walls to funded institutions, enabling it to have a greater and wider impact on data science than ever before. NIH plans to work with Congress to implement the necessary infrastructure changes to move this vision forward.
“The pace of change in biomedical data science is moving at lightning speed with the increasing use of big data and the melding of many diverse data types,” said Dr Collins. “It is critical that NIH pave the path forward for data science, and this move will enable researchers, medical practitioners and many others to use the wealth of vast knowledge and data available to them through the NLM.”
To capitalize on the emerging opportunities in data science, Dr Collins tasked a working group of his ACD to lay out a strategic vision for the NLM to maintain its global leadership in biomedical and health information. Comprised of experts in the fields of biomedical research, bioinformatics, library sciences, publishing, and patient care, the working group assessed the current mission, organization and programmatic priorities of the NLM. The group presented its recommendations for a strategic vision to the ACD, and it was subsequently unanimously endorsed. In summary, the ACD envisioned NLM to be a modernized conceptualization of a library and formulated a series of recommendations to guide its future:
• Continually evolve to remain a leader in assimilating and disseminating accessible and authoritative biomedical research findings and trusted health information to the public, healthcare professionals, and researchers worldwide.
• Lead efforts to support and catalyze open science, data sharing, and research reproducibility, striving to promote the concept that biomedical information and its transparent analysis are public goods.
• Be the intellectual and programmatic epicenter for data science at NIH, including becoming the center of intellectual and programmatic activities in biomedical data science, and stimulate its advancement throughout biomedical research and application.
• Strengthen its role in fostering the future generation of professionals in biomedical informatics, data science, library sciences, and related disciplines through sustained and focused training efforts.
• Maintain, preserve, and make accessible the nation’s historical efforts in advancing biomedical research and medicine, thereby ensuring that this legacy is both safe and accessible for long-term use.
• Have new NLM leadership evaluate what talent, resources, and organizational structures are required to ensure NLM can fully achieve its mission and best allocate its resources.
Dr Collins accepted the ACD recommendations in full, but acknowledged that NIH will need to consider the requirements and infrastructure implications for centering NIH’s biomedical data science activities within the NLM. In addition, NIH has launched a nationwide search for the director of the NLM to replace Donald Lindberg, who served as the NLM director for more than 30 years and retired in March 2015.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance